Risk Assessment Paradigm: An Opportunity for Rationalizing the Choice of Biological Indicator during the Validation of Isolator Biodecontamination Cycles

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.